Ellagic acid is a complex planar molecule which demonstrates a variety
of anticarcinogenic activities. Ellagic acid has been shown to inhibi
t the CYP1A1-dependent activation of benzo[a]pyrene; to bind to and de
toxify the diolepoxide of benzo[a]pyrene; to bind to DNA and reduce th
e formation of O-6-methylguanine by methylating carcinogens; and to in
duce the phase II detoxification enzymes glutathione S-transferase Ya
and NAD(P)H:quinone reductase, Chemical analogs of ellagic acid were s
ynthesized to examine the relationship between the hydroxyl and lacton
e groups of the ellagic acid molecule and its different anticarcinogen
ic activities, These studies demonstrated that both the 3-hydroxyl and
the 4-hydroxyl groups were required for ellagic acid to directly deto
xify the diolepoxide of benzo[a]pyrene, while only the 4-hydroxyl grou
ps were necessary for ellagic acid to inhibit CYP1A1-dependent benzo[a
]pyrene hydroxylase activity, Induction of glutathione S-transferase Y
a and NAD(P):quinone reductase required the lactone groups of ellagic
acid, but the hydroxyl groups were not required for the induction of t
hese phase II enzymes, In addition, the lactone groups, but not the hy
droxyl groups, were required for the analogs to reduce the carcinogen-
induced formation of O-6-methylguanine. Thus, different portions of th
e ellagic acid molecule are responsible for its different putative ant
icarcinogenic activities.